RA
MODV

Royce & Associates’s ModivCare MODV Stock Holding History

Royce & Associates’s Portfolio MODV Stock Details MODV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-25,000
Closed -$357K – 879
2024
Q3 		$357K Hold
25,000
– – ﹤0.01% 815
2024
Q2 		$656K Sell
25,000
-1,736
-6% -$43.9K 0.01% 766
2024
Q1 		$627K Sell
26,736
-105,164
-80% -$3.85M 0.01% 771
2023
Q4 		$5.8M Buy
131,900
+66,900
+103% +$2.64M 0.05% 461
2023
Q3 		$2.05M Buy
+65,000
New +$2.54M 0.02% 636
2022
Q2 		– Sell
-5,088
Closed -$587K – 968
2022
Q1 		$587K Sell
5,088
-34,656
-87% -$4M 0.01% 863
2021
Q4 		$5.89M Buy
39,744
+1,640
+4% +$254K 0.04% 524
2021
Q3 		$6.92M Buy
38,104
+2,270
+6% +$404K 0.05% 518
2021
Q2 		$6.09M Buy
35,834
+672
+2% +$101K 0.04% 565
2021
Q1 		$5.21M Buy
35,162
+11,363
+48% +$1.77M 0.04% 591
2020
Q4 		$3.3M Buy
+23,799
New +$2.95M 0.03% 638
2019
Q3 		– Sell
-22,000
Closed -$1.26M – 1165
2019
Q2 		$1.26M Buy
+22,000
New +$1.43M 0.01% 811

Other funds holding MODV

CCM
Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return
HVCM
HG Vora Capital Management New York $191M AUM 1.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Royce & Associates's MODV Position: Q4 2024 in Review

Royce & Associates sold out of ModivCare (MODV) in Q4 2024, closing a stake of 25,000 shares — an estimated $357K sold.

Royce & Associates first reported a position in MODV in Q2 2019 and held it in 12 quarters. The position peaked at $6.92M in Q3 2021. 101 funds tracked by Wall St. Rank hold MODV as of Q4 2024.

  • Royce & Associates reported no remaining ModivCare position as of Q4 2024 after selling out during the quarter.
  • Royce & Associates sold 25,000 ModivCare shares in Q4 2024, an estimated $357K.
  • Royce & Associates first reported a position in ModivCare in Q2 2019 and held it in 12 quarters.
  • Royce & Associates's ModivCare position peaked at $6.92M in Q3 2021.
  • 101 funds tracked by Wall St. Rank held ModivCare as of Q4 2024.

Based on Royce & Associates's 13F filing for Q4 2024, filed 10 Feb 2025.